AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
Year 2022 Review: Exciting Findings in the Field of Neurology and Neuroscience
The Brain Health Revolution Podcast
Alzheimer's Drug - Cannabab
FDA recently approved a monoclonal antibody, which is now touted as the first Alzheimer's drugs that is going to be available for patients. The administration of this antibody reduced the load of amyloid in patients with early Alzheimer's pathology. After 18 months, there was a 27% slower decline in cognitive scores among participants who received the cannabab compared to those who got placebo.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode